Details for New Drug Application (NDA): 060014
✉ Email this page to a colleague
NDA 060014 describes PERMAPEN, which is a drug marketed by Casper Pharma Llc and is included in one NDA. Additional details are available on the PERMAPEN profile page.
The generic ingredient in PERMAPEN is penicillin g benzathine. There are ninety-two drug master file entries for this compound. Two suppliers are listed for this compound. Additional details are available on the penicillin g benzathine profile page.
The generic ingredient in PERMAPEN is penicillin g benzathine. There are ninety-two drug master file entries for this compound. Two suppliers are listed for this compound. Additional details are available on the penicillin g benzathine profile page.
Summary for 060014
| Tradename: | PERMAPEN |
| Applicant: | Casper Pharma Llc |
| Ingredient: | penicillin g benzathine |
| Patents: | 0 |
Medical Subject Heading (MeSH) Categories for 060014
Profile for product number 001
| Active Rx/OTC/Discontinued: | DISCN | Dosage: | INJECTABLE;INJECTION | Strength | 600,000 UNITS/ML | ||||
| Approval Date: | Approved Prior to Jan 1, 1982 | TE: | RLD: | No | |||||
Complete Access Available with Subscription
